StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)

Close on Nov 16, 2026Market cap $7.16BP/E –Yield –

10x Genomics operating margin

Operating margin is operating income as a percentage of revenue.

10x Genomics's operating margin for the twelve months ending Sep 30, 2026 was -11.7%. For fiscal 2025 it was -9.5%, against -31.9% the year before. The highest annual figure on record is -9.5% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-9.5%+22.4
FY2024Dec 31, 2024-31.9%+11.0
FY2023Dec 31, 2023-42.9%−10.4
FY2022Dec 31, 2022-32.5%−21.9
FY2021Dec 31, 2021-10.7%+168.1
FY2020Dec 31, 2020-178.7%−166.3
FY2019Dec 31, 2019-12.4%+63.3
FY2018Dec 31, 2018-75.7%−49.9
FY2017Dec 31, 2017-25.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-10.7%+11.0
Q2 FY2026Jun 30, 2026-12.9%−30.4
Q1 FY2026Mar 31, 2026-11.3%+14.1
Q4 FY2025Dec 31, 2025-11.8%+18.4
Q3 FY2025Sep 30, 2025-21.6%+5.7
Q2 FY2025Jun 30, 202517.4%+44.7
Q1 FY2025Mar 31, 2025-25.4%+18.2
Q4 FY2024Dec 31, 2024-30.2%−0.2
Q3 FY2024Sep 30, 2024-27.4%+34.3
Q2 FY2024Jun 30, 2024-27.3%+15.9
Q1 FY2024Mar 31, 2024-43.6%−4.9
Q4 FY2023Dec 31, 2023-30.0%−15.2
Q3 FY2023Sep 30, 2023-61.7%−31.2
Q2 FY2023Jun 30, 2023-43.2%+11.9
Q1 FY2023Mar 31, 2023-38.7%−2.3
Q4 FY2022Dec 31, 2022-14.8%−3.8
Q3 FY2022Sep 30, 2022-30.5%−17.8
Q2 FY2022Jun 30, 2022-55.1%−46.2
Q1 FY2022Mar 31, 2022-36.5%−26.8
Q4 FY2021Dec 31, 2021-11.0%+354.0
Q3 FY2021Sep 30, 2021-12.7%+78.2
Q2 FY2021Jun 30, 2021-8.9%+83.0
Q1 FY2021Mar 31, 2021-9.7%+18.0
Q4 FY2020Dec 31, 2020-365.0%−354.3
Q3 FY2020Sep 30, 2020-90.9%−76.0
Q2 FY2020Jun 30, 2020-91.9%−73.3
Q1 FY2020Mar 31, 2020-27.7%−22.0
Q4 FY2019Dec 31, 2019-10.7%+137.6
Q3 FY2019Sep 30, 2019-14.9%+25.9
Q2 FY2019Jun 30, 2019-18.6%–
Q1 FY2019Mar 31, 2019-5.7%–
Q4 FY2018Dec 31, 2018-148.3%–
Q3 FY2018Sep 30, 2018-40.8%–

More 10x Genomics figures

See a number that looks wrong?